E

Encoded Therapeutics

Precision gene therapies for pediatric CNS.

Associate Director, Global HEOR and Evidence Generation

Biology & BiotechUpdated on Nov 12
Full-timeRemote in USA

About the Job

Requirements

  • A Master's degree (MS or MPH), MD, PharmD, or PhD in Health Economics and Outcomes Research (HEOR), Epidemiology, Biostatistics, Public Health, Psychology, or a related quantitative/scientific discipline is required.
  • At least 5 years of relevant pharmaceutical industry or specialized consulting experience is required.
  • A proven track record in study design and execution across observational research, Patient Experience Data (PED), Clinical Outcome Assessments (COA/PRO) development, psychometric validation, and health economic modeling is required.
  • Demonstrated ability to lead HEOR research from conceptualization and protocol development through peer-reviewed scientific publication and defense before global health authorities is required.
  • Direct experience preparing and delivering HEOR components for global regulatory dossiers and Health Technology Assessment (HTA) submissions is required.
  • Strong project management skills and a history of managing multiple complex projects, budgets, and external vendor partnerships in rapidly changing global matrix environments are required.
  • Strong working knowledge of pharmaceutical compliance frameworks, legal/regulatory review processes, and clinical trial designs is required.
  • Willingness to travel domestically and internationally as needed to support research initiatives and global business priorities is required.

Responsibilities

  • Shape, align, and support the execution of global HEOR strategies to support product approval, clinical differentiation, and optimal patient access for company assets.
  • Maintain a deep understanding of global Health Technology Assessment (HTA) requirements, major ex-US HTA bodies, and the evolving US payer and value assessment landscape to shape evidence generation.
  • Execute HEOR-related commercial strategies to support successful asset launches.
  • Partner with Clinical, Regulatory, Commercial, Medical Affairs, and Patient Advocacy as a subject-matter expert to integrate HEOR into the broader global evidence generation strategy.
  • Maintain working knowledge of global regulatory guidelines, internal compliance policies, and Medical-Legal-Regulatory (MLR) review processes to ensure activities meet ethical standards.
  • Lead global HEOR research initiatives, including literature reviews, natural history, disease burden, observational research, Clinical Outcomes Assessments (COA/PRO), and health economic and epidemiological modeling.
  • Lead systematic landscape assessments and data gap analyses to inform asset strategy, contextualize disease burden, and identify optimal data sources.
  • Oversee planning, budgeting, execution, and timely dissemination of research findings, managing external vendors and scientific partnerships to align objectives and timelines.
  • Maintain scientific rigor and quality across proposals, protocols, and statistical analysis plans, and defend research in internal and external forums.
  • Develop and implement best practices, governance frameworks, and educational resources as needed to scale HEOR standards and capabilities across the organization.
  • Champion the HEOR and payer perspective internally and contribute to corporate initiatives that embed a value-driven mindset across the organization.

Desired Qualifications

  • A PhD in HEOR or a related scientific discipline is preferred.
  • Direct experience supporting programs in rare genetic disorders, neurology (specifically epilepsy, neurodevelopmental disorders, or pain), or advanced therapeutics such as gene and cell therapies is preferred.
  • Hands-on experience supporting assets through late-stage development, pre-launch commercialization, and global launch execution is preferred.

About the Company

Encoded Therapeutics

Precision gene therapies for pediatric CNS.

Encoded Therapeutics develops precision gene therapies for pediatric CNS disorders such as Dravet syndrome, using a targeting and regulation platform that directs genetic payloads to specific brain cell types based on genetic profiles. The approach aims to increase gene specificity, cell selectivity, and potency, while reducing off-target effects and toxicity. Therapies are designed to modify disease-causing genes in defined brain cells to provide lasting benefits. The company plans to translate these therapies into clinically effective treatments and commercialize them through partnerships with healthcare providers.

Company size
51-200
Company stage
Series F
Total funding
$514.1M
Headquarters
San Francisco, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Encoded Therapeutics

See more jobs